Salta al contenuto principale
Passa alla visualizzazione normale.

ROBERTO MONASTERO

From Small Peptides to Large Proteins against Alzheimer'sDisease

  • Autori: Picone, Pasquale; Sanfilippo, Tiziana; Vasto, Sonya; Baldassano, Sara; Guggino, Rossella; Nuzzo, Domenico; Bulone, Donatella; San Biagio, Pier Luigi; Muscolino, Emanuela; Monastero, Roberto; Dispenza, Clelia; Giacomazza, Daniela
  • Anno di pubblicazione: 2022
  • Tipologia: Review essay (rassegna critica)
  • OA Link: http://hdl.handle.net/10447/577049

Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disorder in the elderly. The two cardinal neuropathological hallmarks of AD are the senile plaques, which are extracellular deposits mainly constituted by beta-amyloids, and neurofibrillary tangles formed by abnormally phosphorylated Tau (p-Tau) located in the cytoplasm of neurons. Although the research has made relevant progress in the management of the disease, the treatment is still lacking. Only symptomatic medications exist for the disease, and, in the meantime, laboratories worldwide are investigating disease-modifying treatments for AD. In the present review, results centered on the use of peptides of different sizes involved in AD are presented.